… recommendations for the diagnosis, treatment and follow-up of non-alcoholic fatty liver disease
(NAFLD… European Association for the Study of the Liver (EASL), European Association …

… The purpose of this commentary is to discuss briefly the EASL–EASD–EASO clinical
practice guidelines with a focus on their relevance for clinicians caring for patients with type 2 …

… application of the EASL–EASD–EASO guidelines in a routine clinical practice setting in a …
with NAFLD in the cohort. The retrospective application of EASL–EASD–EASO guidelines …

… The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and
follow-up of non-alcoholic fatty liver disease (NAFLD) patients and are the product of a joint …

… , non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic
liver disease … NAFLD includes two distinct conditions with different histological features and …

… of the EASL-EASD-EASO clinical practice guidelines for the management of NAFLD in …
application of the EASL-EASD-EASO algorithm for the diagnosis, treatment and follow-up of …

… The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and
follow-up of non-alcoholic fatty liver disease (NAFLD) patients and are the product of a joint …

… consumption), and a lack of exercise contribute to fatty liver disease. Non-alcoholic fatty
liver disease (NAFLD) is a clinical histological spectrum ranging from steatosis to non-alcoholic …

… Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic
fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …

… ) “EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty
liver disease” … for the Study of The Liver (EASL), published in 2016[3]; (2) “Nonalcoholic fatty …